These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 21812056

  • 1. Identification of selective ligands for human fibrin recognition using high-throughput docking.
    Massarelli I, Imbriani M, Chiellini F, Chiellini E, Bianucci AM.
    J Mol Recognit; 2011; 24(5):824-32. PubMed ID: 21812056
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Design of highly specific ligands of fibrin for therapeutic applications.
    Bianucci AM, Massarelli I, Chiellini F, Eidelman C, Chiellini E.
    J Biomater Sci Polym Ed; 2004; 15(9):1203-22. PubMed ID: 15503635
    [Abstract] [Full Text] [Related]

  • 4. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
    Floriano WB, Vaidehi N, Zamanakos G, Goddard WA.
    J Med Chem; 2004 Jan 01; 47(1):56-71. PubMed ID: 14695820
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins.
    Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, Roudier J, Serre G.
    Eur J Immunol; 2006 Aug 01; 36(8):2250-63. PubMed ID: 16838278
    [Abstract] [Full Text] [Related]

  • 8. Finding more needles in the haystack: A simple and efficient method for improving high-throughput docking results.
    Klon AE, Glick M, Thoma M, Acklin P, Davies JW.
    J Med Chem; 2004 May 20; 47(11):2743-9. PubMed ID: 15139752
    [Abstract] [Full Text] [Related]

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 20; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Virtual screening for lead discovery.
    Tang YT, Marshall GR.
    Methods Mol Biol; 2011 Dec 20; 716():1-22. PubMed ID: 21318897
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
    Mosesson MW.
    Blood Coagul Fibrinolysis; 1997 Jul 20; 8(5):257-67. PubMed ID: 9282789
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW, Siebenlist KR, Voskuilen M, Nieuwenhuizen W.
    Thromb Haemost; 1998 Apr 20; 79(4):796-801. PubMed ID: 9569195
    [Abstract] [Full Text] [Related]

  • 16. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes.
    Tasset DM, Kubik MF, Steiner W.
    J Mol Biol; 1997 Oct 10; 272(5):688-98. PubMed ID: 9368651
    [Abstract] [Full Text] [Related]

  • 17. Is it possible docking and scoring new ligands with few experimental data? Preliminary results on estrogen receptor as a case study.
    Cozzini P, Dottorini T.
    Eur J Med Chem; 2004 Jul 10; 39(7):601-9. PubMed ID: 15236840
    [Abstract] [Full Text] [Related]

  • 18. Fast structure-based virtual ligand screening combining FRED, DOCK, and Surflex.
    Miteva MA, Lee WH, Montes MO, Villoutreix BO.
    J Med Chem; 2005 Sep 22; 48(19):6012-22. PubMed ID: 16162004
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.